Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease

Journal of Hepatology

Volumn 32, Issue 2, 2000, Pages 209-217

  Zein, Nizar N ^a,d   Abdulkarim, Ahmad S ^b   Wiesner, Russell H ^a   Egan, Kathleen S ^c   Persing, David H ^b  

^a Div Gastroenterol Hepatol Int M   (United States)

^b Dept of Lab Medicne and Pathology ^*  (United States)

^c MAYO CLINIC   (United States)

^d Nizar N Zein   (United States)

Author keywords

Alcoholic liver disease; Cirrhosis; Diabetes mellitus; Disease; Endpoints; Hepatitis; Liver; Outcome; Transplantation

Indexed keywords

GLUCOSE; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; VIRUS RNA;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; HEPATITIS C; HEPATITIS G VIRUS; HLA SYSTEM; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0033983645     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80065-3     Document Type: Article

References (53)

1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 15:1995;5-14.
2. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med. 123:1995;330-337.
3. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II [letter]. J Infect Dis. 162:1990;569.
4. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 123:1995;615-620.
5. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol. 9:1991;621-624.
6. DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology. 17:1993;551-557.
7. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 328:1993;465-470.
8. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 101:1994;736-745.
9. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 339:1992;321-323.
10. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study. BMJ. 300:1990;227-230.
11. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T, et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis. 146:1992;266-268.
12. Stone BG, Van Thiel DH. Diabetes mellitus and the liver. Semin Liver Dis. 5:1985;8-28.
13. Gray H, Wreghitt T, Stratton IM, Alexander GJ, Turner RC, O'Rahilly S. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med. 12:1995;244-249.
14. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care. 19:1996;998-1000.
15. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 21:1994;1135-1139.
16. Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR, et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol. 93:1998;2363-2367.
17. Linnen J, Wages J Jr, ZhangKeck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
18. Pessoa MG, Wright TL. Hepatitis G: a virus in search of a disease. Hepatology. 24:1996;461-463.
19. Alter HJ. The cloning and clinical implications of HGV and HGBV-C (editorial). N Engl J Med. 334:1996;1536-1537.
20. Di Bisceglie AM. Hepatitis G virus infection: a work in progress (editorial). Ann Intern Med. 125:1996;772-773.
21. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [letter]. N Engl J Med. 334:1996;195-196.
22. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
23. Tanaka E, Alter HJ, Nakatsuji Y, Shih JW, Kim JP, Matsumoto A, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 125:1996;740-743.
24. Leibson CL, O'Brien PC, Atkinson E, Palumbo PJ, Melton LJ III. Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study. Am J Epidemiol. 146:1997;12-22.
25. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
26. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 21:(Suppl 1):1998;S5-S19.
27. Zein NN, McGreger CG, Wendt NK, Schwab K, Mitchell PS, Persing DH, et al. Prevalence and outcome of hepatitis C infection among heart transplant recipients. J Heart Lung Transplant. 14:1995;865-869.
28. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med. 125:1996;634-639.
29. Program manual for GCG package, version 7. Madison, Wisconsin 53711. April 1991.
30. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [letter]. Hepatology. 19:1994;1321-1324.
31. Czaja AJ, Rakela J, Hay JE, Moore SB. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology. 98:1990;1587-1593.
32. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 25:1997;317-323.
33. Petrides AS, DePronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev. 5:1989;691-709.
34. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 2:1967;1051-1056.
35. Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab. 51:1980;1030-1036.
36. Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 14:1991;103-111.
37. Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes. 103:1995;63-74.
38. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci. 32:1996;526-530.
39. del Olmo JA, Serra MA, Rodrigo JM. Liver cirrhosis and diabetes mellitus [letter]. J Hepatol. 24:1996;645.
40. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 29:1999;328-333.
41. Fiore G, Fera G, Napoli N, Vella F, Schiraldi O. Liver steatosis and chronic hepatitis C: a spurious association? Eur J Gastroenterol Hepatol. 8:1996;125-129.
42. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol. 92:1997;1298-1301.
43. Eaton S, Record CO, Bartlett K. Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur J Clin Invest. 27:1997;719-722.
44. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 19:1995;846-850.
45. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology. 19:1994;616-627.
46. Ludwig J, McGill DB, Lindor KD. Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 12:1997;398-403.
47. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
48. Chin CF, Zein NN. Extrahepatic syndromes associated with hepatitis C infection. Gastroenterol Int. 11:1998;26-35.
49. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 46:1997;1701-1710.
50. Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 41:1992;1473-1490.
51. Zein NN, Persing DH, Czaja AJ. Viral and genetic factors as determinants of autoimmune expression in chronic hepatitis C [abstract]. Gastroenterology. 110:(Suppl):1996;A1367.
52. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol. 25:1996;64-71.
53. Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery. 1:(14):1993;650-656.